Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ALUPENT LIQ 50MG/ML 50 MG

ORCIPRENALINE SULFATE : 50 MG · DIN 00003859 · BOEHRINGER INGELHEIM (CANADA) LTD LTEE

Health Canada status: CANCELLED POST MARKET

What is ALUPENT LIQ 50MG/ML?

ALUPENT LIQ 50MG/ML 50 MG contains ORCIPRENALINE SULFATE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 00003859, held by BOEHRINGER INGELHEIM (CANADA) LTD LTEE, supplied as LIQUID for ORAL ; INHALATION administration. Health Canada currently lists it as cancelled post market, status dated 14-Aug-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN00003859
Brand nameALUPENT LIQ 50MG/ML
Generic / active ingredientORCIPRENALINE SULFATE : 50 MG
ManufacturerBOEHRINGER INGELHEIM (CANADA) LTD LTEE
Strength50 MG
Dosage formLIQUID
Route of administrationORAL ; INHALATION
SchedulePrescription
ATC codeR03AB03 ORCIPRENALINE
AHFS class68:16.04
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date14-Aug-1997
Original market date1951-12-31 00:00:00

What can be used instead?

Other Canadian products sharing ATC code R03AB03 ORCIPRENALINE. 0 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
ALUPENT AER.75 MGAEROSOLBOEHRINGER INGELHEIM (CANADA) LTD LTEECANCELLED POST MARKETDIN 00254134

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for ALUPENT LIQ 50MG/ML

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for ALUPENT LIQ 50MG/ML

Health Canada Drug Product Database (DPD), DIN 00003859. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.